These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25973667)

  • 1. Anticancer Agents: Does a Phosphonium Behave Like a Gold(I) Phosphine Complex? Let a "Smart" Probe Answer!
    Ali M; Dondaine L; Adolle A; Sampaio C; Chotard F; Richard P; Denat F; Bettaieb A; Le Gendre P; Laurens V; Goze C; Paul C; Bodio E
    J Med Chem; 2015 Jun; 58(11):4521-8. PubMed ID: 25973667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphine-gold(I) compounds as anticancer agents: general description and mechanisms of action.
    Lima JC; Rodriguez L
    Anticancer Agents Med Chem; 2011 Dec; 11(10):921-8. PubMed ID: 21864238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naphthalimide gold(I) phosphine complexes as anticancer metallodrugs.
    Bagowski CP; You Y; Scheffler H; Vlecken DH; Schmitz DJ; Ott I
    Dalton Trans; 2009 Dec; (48):10799-805. PubMed ID: 20023909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new target for gold(I) compounds: glutathione-S-transferase inhibition by auranofin.
    De Luca A; Hartinger CG; Dyson PJ; Lo Bello M; Casini A
    J Inorg Biochem; 2013 Feb; 119():38-42. PubMed ID: 23183361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of gold(I) phosphine complexes containing the 2-BrC
    Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
    Eur J Med Chem; 2018 Feb; 145():291-301. PubMed ID: 29331752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of organometallic gold(I) derivatives as anticancer agents.
    García-Moreno E; Tomás A; Atrián-Blasco E; Gascón S; Romanos E; Rodriguez-Yoldi MJ; Cerrada E; Laguna M
    Dalton Trans; 2016 Feb; 45(6):2462-75. PubMed ID: 26469679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly cytotoxic bioconjugated gold(I) complexes with cysteine-containing dipeptides.
    Gutiérrez A; Marzo I; Cativiela C; Laguna A; Gimeno MC
    Chemistry; 2015 Jul; 21(31):11088-95. PubMed ID: 26111275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conception and Evaluation of Fluorescent Phosphine-Gold Complexes: From Synthesis to in vivo Investigations.
    Rousselle B; Massot A; Privat M; Dondaine L; Trommenschlager A; Bouyer F; Bayardon J; Ghiringhelli F; Bettaieb A; Goze C; Paul C; Malacea-Kabbara R; Bodio E
    ChemMedChem; 2022 Jun; 17(11):e202100773. PubMed ID: 35254001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents.
    Chaves JDS; Tunes LG; de J Franco CH; Francisco TM; Corrêa CC; Murta SMF; Monte-Neto RL; Silva H; Fontes APS; de Almeida MV
    Eur J Med Chem; 2017 Feb; 127():727-739. PubMed ID: 27823888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.
    Rackham O; Nichols SJ; Leedman PJ; Berners-Price SJ; Filipovska A
    Biochem Pharmacol; 2007 Oct; 74(7):992-1002. PubMed ID: 17697672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seleno-auranofin (Et3PAuSe-tagl): synthesis, spectroscopic (EXAFS, 197Au Mössbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) characterization, biological activity, and rapid serum albumin-induced triethylphosphine oxide generation.
    Hill DT; Isab AA; Griswold DE; DiMartino MJ; Matz ED; Figueroa AL; Wawro JE; DeBrosse C; Reiff WM; Elder RC; Jones B; Webb JW; Shaw CF
    Inorg Chem; 2010 Sep; 49(17):7663-75. PubMed ID: 20704360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Structure-Activity Relationship Study of Antimicrobial Auranofin against ESKAPE Pathogens.
    Wu B; Yang X; Yan M
    J Med Chem; 2019 Sep; 62(17):7751-7768. PubMed ID: 31386365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micelles based on gold-glycopolymer complexes as new chemotherapy drug delivery agents.
    Pearson S; Scarano W; Stenzel MH
    Chem Commun (Camb); 2012 May; 48(39):4695-7. PubMed ID: 22473015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections.
    Feng L; Pomel S; Latre de Late P; Taravaud A; Loiseau PM; Maes L; Cho-Ngwa F; Bulman CA; Fischer C; Sakanari JA; Ziniel PD; Williams DL; Davioud-Charvet E
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33139647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of a cationic gold(I) complex and disulfide by oxidation of the antiarthritic gold drug auranofin.
    Mohamed AA; Chen J; Bruce AE; Bruce MR; Krause Bauer JA; Hill DT
    Inorg Chem; 2003 Apr; 42(7):2203-5. PubMed ID: 12665352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues.
    Cirri D; Geri A; Massai L; Mannelli M; Gamberi T; Magherini F; Becatti M; Gabbiani C; Pratesi A; Messori L
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety.
    Ronga L; Tolbatov I; Giorgi E; Pisarek P; Enjalbal C; Marrone A; Tesauro D; Lobinski R; Marzo T; Cirri D; Pratesi A
    Inorg Chem; 2023 Jul; 62(26):10389-10396. PubMed ID: 37342994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antioxidant 2,6-di-tert-butylphenol moiety attenuates the pro-oxidant properties of the auranofin analogue.
    Shpakovsky DB; Shtil AA; Kharitonashvili EV; Tyurin VY; Antonenko TA; Nazarov AA; Osipova VP; Berberova NT; Foteeva LS; Schmidt C; Ott I; Milaeva ER
    Metallomics; 2018 Mar; 10(3):406-413. PubMed ID: 29399682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the biological properties of alkynyl phosphine gold(I) complexes.
    Meyer A; Bagowski CP; Kokoschka M; Stefanopoulou M; Alborzinia H; Can S; Vlecken DH; Sheldrick WS; Wölfl S; Ott I
    Angew Chem Int Ed Engl; 2012 Aug; 51(35):8895-9. PubMed ID: 22848030
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticancer gold(I)-phosphine complexes as potent autophagy-inducing agents.
    Tian S; Siu FM; Kui SC; Lok CN; Che CM
    Chem Commun (Camb); 2011 Sep; 47(33):9318-20. PubMed ID: 21584293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.